Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.8129 | ||
| Change(%) | ![]() | +0.0029 | |
| Volume | 281597 | ||
| 2:02 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon to Present at BMO Capital Markets Focus on Healthcare Conference
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances--
Enzon Reports Solid Third Quarter 2008 Results
-- Provides update on the sale of the specialty pharma business --
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

Enzon Presents New Data on its LNA Programs
--Platform shows promise--
Enzon Eliminates its Remaining 2008 Debt
Enzon Pharmaceuticals to Add New Independent Director to Board
Enzon Reports Significant Progress on the Reduction of Its Debt
